9104AALL1731-NCT03914625OpenA Phase 3 Trial Investigating Blinatumomab (IND# 117467, NSC# 765986) in Combination with Chemotherapy in Patients with Newly Diagnosed Standard Risk or Down syndrome B-Lymphoblastic Leukemia (B-ALL) and the Treatment of Patients with Localized B-Lymphoblastic Lymphoma (B-LLy)NCT03914625NationalChildrenTreatmentIII (Cancer Control)YGlobalLeukemia, otherPudela, CaileighPediatricsOncology GroupLombardi Comprehensive Cancer Center (LCCC)- 12423Abigail MoskovAbigail Moskov+1 202-444-3202alm387@georgetown.eduClinical Research Coordinator
2021R3.1 Build 22 <a href="https://advarra.com" target="_blank">© 2024 Advarra, Inc.</a>